Sesame Summit 2026 – application open

Best HealthTech Events

Not seeing your favorite HealthTech event here? smrs/link.add-event

Upcoming HealthTech events

The Festival of Biologics 2023

Mar 20-22 – USA
The Festival of Biologics brings together pharma & biotech, academics, and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy, and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing, and commercial challenges involved in bringing new therapies to market.

ViVE 2023

Mar 26-29 – USA
ViVE provides a fresh, curated education and networking experience for digital health leaders, disruptors and influencers. They’re bringing together C-suite executives, senior digital health leaders and buyers, health startups and investors, and government and solution providers to advance healthcare.

Reuters Events: Pharma 2023

Apr 18-20 – Spain
Join 100s of your peers at one of the world’s gatherings for pharma pioneers and health innovators. One of the biggest, most senior, and cross-functional commercial pharma events.

LSX World Congress 2023

May 3-4 – UK
The 9th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

Future Health Summit 2023

May 24-25 – Ireland
This internationally distinguished event is an Irish and International gathering of the brightest minds in the healthcare industry with an illustrious audience of over 500 high end (C-Suite) industry delegates attending. Featuring renowned speakers from Ireland, USA, UK, Europe, and further afar.

DHIS 2023

Jun 7 – USA
The Digital Healthcare Innovation Summit (DHIS) is an unparalleled annual gathering of the leading innovators, investors, payers, providers, and policymakers who are driving the digital health revolution.

HIMSS 2023

Jun 7-9 – Portugal
HIMSS23 in Lisbon is one of the most influential health information and technology conferences and exhibitions in Europe – where healthcare leaders meet to build relationships during lively networking events, learn from experts in hot topic education sessions and discover innovative health tech products to solve their greatest challenges.

World Medical Innovation Forum 2023

Jun 12-14 – USA
How will gene and cell therapy change health care? Join CEOs, industry leaders, and Harvard’s top medical faculty to assess the future of medicine and the specific actions needed to realize the promise of emerging research for patients everywhere.

Bits & Pretzels HealthTech 2023

Jun 20-21 – Germany
Get ready to unite with the greatest minds in HealthTech! From Pharma and Tech Giants, to MedTech professionals and Policymakers- Bits & Pretzels HealthTech is bringing them all together. With startup founders at its heart, it’s an opportunity like no other for insightful collaboration with a positive ripple effect on European healthcare.

DxPx US 2023

Jul 25-27 – USA
With the gaining importance of diagnostics, digital health, precision medicine, and life science tools, there‘s a need for a dedicated platform to bring together the relevant stakeholders and further drive our industries.

Intelligent Health 2023

Sept 13-14 – Switzerland
Intelligent health will bring together the global AI and health communities to advance discussions on how to apply AI and drive technological collaboration in healthcare.

HETT 2023

Sept 26-27 – UK
HETT 2023 will explore the systems and infrastructure that underpin and enable a data-driven NHS, supporting the ecosystem to deliver patient outcomes through the meaningful implementation of technology.

The MedTech Conference 2023

Oct 9-11 – USA
Featuring world-class plenary speakers, cross-cutting educational programming, valuable networking, and business development opportunities, The MedTech Conference is a must-attend event for the industry’s prominent and most promising companies.

Reuters Events: Total Health 2023

Nov 7-8 – USA
Healthcare is still in crisis. Lessons learned during the pandemic – urgency, collaboration, speed of innovation – must now be applied to build a better healthcare system. As the world looks to the healthcare industry for guidance, Total Health is where its leaders come to set the agenda and change lives.

Frontiers Health 2023

Nov 8-9 – Italy
Frontiers Health emerged as one of the premier global digital health innovation events, with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development.

MEDICA 2023

Nov 13-16 – Germany
Discover the full range of solutions for medical practices, clinics, and hospitals, and showcase your own. Given the focus on current as well as upcoming challenges, these are more indispensable than ever. Personal protective equipment, hygiene supplies, disposables, and much more.

GIANT Health London 2023

Nov 23-24 – UK
The GIANT (Global Innovation and New Technology) Health Event is one of the UK’s leading, unmissable healthcare innovation festival; with 4 “shows within the festival”. Come meet, network, learn, and do business with 100s of world-class speakers, immersive innovation presentations, the UK’s leading health-tech startups pitching to investors show, and more.


Past Events

CES 2023

Jan 5-8 – USA
CES one of the world’s most influential technology events will return to Las Vegas, Nevada giving the global audience access to major brands and startups, as well as the industry’s most influential leaders and advocates.

IMSH 2023

Jan 21-25 – USA
The International Meeting on Simulation in Healthcare (IMSH) is a scientific conference that explores the latest innovations and best practices in healthcare simulation. IMSH provides the tools and resources healthcare professionals need to advance their skills, impact change in delivery systems and practice, and, ultimately, improve patient safety.

you might also like

Fundraising 4 hours ago

London-based AI laboratory Ineffable Intelligence has emerged from stealth with a $1.1 billion seed round at a $5.1 billion post-money valuation, the company confirmed on 27 April 2026. The financing is the largest seed round ever raised by a European company and one of the largest first-money-in rounds in the global history of artificial intelligence. The round was co-led by Sequoia Capital and Lightspeed Venture Partners. Participating investors included Nvidia, DST Global, Index Ventures, Google, and the UK Sovereign AI Fund, the British government’s recently established vehicle for backing strategic AI capacity on home soil. A bet on a different path to general intelligence Ineffable Intelligence was founded in 2025 by David Silver, the former Vice President of Reinforcement Learning at Google DeepMind and the principal architect of AlphaGo, AlphaZero and AlphaStar. He is joined by three further DeepMind alumni: Wojciech Czarnecki, Lasse Espeholt and Junhyuk Oh. All four have spent the past decade at the frontier of reinforcement learning research, the discipline behind some of the most consequential demonstrations of machine learning over the past ten years. The company describes its objective as building a “superlearner” — an AI system capable of acquiring knowledge directly from its own experience rather than from human-generated text or imagery. “Our mission is to make first contact with superintelligence,” Silver said in a statement accompanying the launch. “We are creating a superlearner that discovers all knowledge from its own experience, from elementary motor skills through to profound intellectual breakthroughs.” The framing is a deliberate departure from the dominant industry trajectory. Most leading AI laboratories, including OpenAI, Anthropic and Google DeepMind itself, have built large language models trained primarily on the corpus of the internet, then refined that training with human feedback. Ineffable’s wager is that the marginal returns on scaling text-based pretraining are diminishing and that the next leap in capability will come from agents that learn endlessly from the consequences of their own actions, in much the same way AlphaZero learnt the game of Go without studying any human matches. Why $1.1 billion at seed The size of the round is unusual even by the inflated standards of the 2026 AI capital cycle. Two factors appear to explain it. First, frontier reinforcement learning at the scale Ineffable describes is computationally extraordinarily expensive: the company will need to operate vast simulation environments and train very large models against them, an undertaking that consumes capital at a rate closer to physical R&D than to traditional software. Second, the round signals a strategic move by Europe’s investor and policy ecosystems to retain the most ambitious AI researchers on the continent. The presence of the UK Sovereign AI Fund alongside Sequoia, Lightspeed and Nvidia is the clearest expression of that intent. The British government has publicly framed the investment as a bet on breakthrough AI that “can discover new knowledge”, positioning the country as a willing co-investor in domestic frontier laboratories. For Ineffable, the implication is access not only to capital but to compute, regulatory engagement and the still-resilient academic talent base around UCL, Oxford, Cambridge and Imperial. Founder pledge of historic scale Alongside the funding announcement, Silver disclosed that he is committing 100 per cent of any personal proceeds from his Ineffable equity to charity via the Founders Pledge network — described by the organisation as the largest pledge in its history. At the round’s $5.1 billion valuation, that commitment could ultimately exceed several billion dollars if the company succeeds. It is a meaningful gesture in a sector where the reputational stakes around concentrated AI wealth are escalating, and one likely to be referenced in subsequent founder-led commitments. Implications for the European AI landscape Ineffable’s emergence reshapes the European AI map in three concrete ways. It establishes London as the home of the continent’s largest-ever seed-stage company, complicating Paris’s recent narrative of frontier-AI primacy after Mistral’s earlier rounds. It validates a thesis — that reinforcement learning, not transformer scaling, is the next frontier — that has lately been losing capital share to language-model incumbents. And it confirms that the UK government is now willing to act as a balance-sheet co-investor in domestic AI laboratories, a posture much closer to the French model than to the predominantly grant-based regimes elsewhere in Europe. The execution risk is non-trivial. Reinforcement learning at frontier scale has historically required years of careful environment design before producing competitive systems, and Ineffable’s “first contact” framing sets a high bar against which it will be judged. But for now, with a billion dollars on the balance sheet, four of the discipline’s most accomplished researchers in the founding team and a sovereign co-investor at its back, Ineffable Intelligence is the most heavily resourced new entrant in the European AI cycle. Sesamers covers European fundraising rounds across deeptech, fintech and AI. Source: tech.eu.

Fundraising 5 days ago

Belfast's Cloudsmith has raised $72M Series C led by TCV, with Insight Partners participating, to expand its artifact management platform and secure the AI-era software supply chain.

Fundraising 5 days ago

Berlin’s VREY has raised €3.3M seed led by Rubio Impact Ventures to roll out rooftop solar software for Germany’s multi-family buildings.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.